Herrstedt J, et al. - This study was planned to examine the antiemetic effect of the dopamine D2- and dopamine D3-receptor antagonist, amisulpride, in patients receiving cisplatin-based chemotherapy. Findings demonstrated the antiemetic efficacy of amisulpride against cisplatin-induced acute nausea and vomiting. The outcome against nausea is of particular concern.